HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

How a T cell receptor-like antibody recognizes major histocompatibility complex-bound peptide.

Abstract
We determined the crystal structures of the T cell receptor (TCR)-like antibody 25-D1.16 Fab fragment bound to a complex of SIINFEKL peptide from ovalbumin and the H-2K(b) molecule. Remarkably, this antibody directly "reads" the structure of the major histocompatibility complex (MHC)-bound peptide, employing the canonical diagonal binding mode utilized by most TCRs. This is in marked contrast with another TCR-like antibody, Hyb3, bound to melanoma peptide MAGE-A1 in association with HLA-A1 MHC class I. Hyb3 assumes a non-canonical orientation over its cognate peptide-MHC and appears to recognize a conformational epitope in which the MHC contribution is dominant. We conclude that TCR-like antibodies can recognize MHC-bound peptide via two different mechanisms: one is similar to that exploited by the preponderance of TCRs and the other requires a non-canonical antibody orientation over the peptide-MHC complex.
AuthorsTatiana Mareeva, Erik Martinez-Hackert, Yuri Sykulev
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 283 Issue 43 Pg. 29053-9 (Oct 24 2008) ISSN: 0021-9258 [Print] United States
PMID18703505 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes
  • Immunoglobulin Fab Fragments
  • Peptides
  • Receptors, Antigen, T-Cell
Topics
  • Crystallography, X-Ray
  • Epitopes (chemistry)
  • Immunoglobulin Fab Fragments (chemistry)
  • Major Histocompatibility Complex
  • Models, Biological
  • Models, Molecular
  • Molecular Conformation
  • Peptides (chemistry)
  • Protein Conformation
  • Receptors, Antigen, T-Cell (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: